SCHEMBL7543008

SCHEMBL7543008

N[C@H]1CC=CC2CN(Cc3ccccc3)CCN2C1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ SIGMAR1 Q99720 2/20 0.45
▸ CYP1A2 P05177 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ MC4R P32245 1/20 0.40
▸ TACR1 P25103 2/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ SLC18A3 Q16572 1/20 0.39
▸ ACHE P22303 2/20 0.39
▸ BCHE P06276 1/20 0.39
▸ BACE1 P56817 1/20 0.39
▸ DRD4 P21917 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ FUCA1 P04066 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3604123 0.76 SIGMAR1 (0.65) SIGMAR1CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL7253237 0.75 TACR1 (0.42) SIGMAR1CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL330609 0.70 ACHE (0.58) SIGMAR1CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL14793661 0.70 ACHE (0.58) SIGMAR1CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL239922 0.70 ACHE (0.58) SIGMAR1CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL28962371 0.70 SIGMAR1 (0.67) SIGMAR1MC4RKMT2AACHEDRD4
SCHEMBL42501 0.70 ACHE (0.58) SIGMAR1CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL1088536 0.69 FUCA1 (0.60) SIGMAR1CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL15088847 0.68 S1PR1 (0.47) SIGMAR1ALDH1A1KMT2ALMNA
SCHEMBL13497256 0.68 S1PR1 (0.47) SIGMAR1ALDH1A1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1261610-A2 SUCCINOYLAMINO CARBOCYCLES AND HETEROCYCLES AS INHIBITORS OF A-BETA PROTEIN PRODUCTION Bristol-Myers Squibb Pharma Company (US) 2002-12-04 — — EP disclosed
WO-2001060826-A2 SUCCINOYLAMINO CARBOCYCLES AND HETEROCYCLES AS INHIBITORS OF Aβ PROTEIN PRODUCTION BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2001-08-23 — — WO disclosed
Send feedback